STP122G

N/A

Report date: 2023/04/17 10:28:41
NME

Base Information

Drug NameSTP122G
Drug Alias NameSTP-122GSTP122G
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsEmbolism and Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomics Ltd
Inactive CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Active IndicationsEmbolism and Thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A